General description
Carboplatin is a platinum-based antineoplastic agent used to treat many types of cancer.
INN
Carboplatin
ATC codes
Medicine type
Chemical agent
EML status history
First added in 2009
(TRS
958)
for
Other specified carcinomas of ovary
Added in 2009
(TRS
958)
for
Retinoblastoma
Added in 2009
(TRS
958)
for
Osteosarcoma of bone and articular cartilage of unspecified sites
Added in 2009
(TRS
958)
for
Malignant neoplasms of breast
Added in 2009
(TRS
958)
for
Other specified malignant neoplasms of bronchus or lung
Added in 2009
(TRS
958)
for
Malignant neoplasms of nasopharynx
Added in 2019
(TRS
1021)
for
Malignant neoplasms of cervix uteri
Added in 2021
(TRS
1035)
for
Other specified gliomas of brain
Added in 2021
(TRS
1035)
for
Malignant neoplasms of lip, oral cavity or pharynx
Added in 2021
(TRS
1035)
for
Malignant neoplasms of kidney, except renal pelvis
Added in 2021
(TRS
1035)
for
Other specified malignant neoplasms of the ovary
Added in 2021
(TRS
1035)
for
Germ cell tumour of testis
Wikipedia
DrugBank
Recommendations
Section
Cytotoxic medicines
- Parenteral > General injections > IV: 50 mg per 5 mL; 150 mg per 15 mL; 450 mg per 45 mL; 600 mg per 60 mL
Indications
Other specified carcinomas of ovary
Retinoblastoma
Osteosarcoma of bone and articular cartilage of unspecified sites
Malignant neoplasms of breast
Malignant neoplasms of nasopharynx
Other specified malignant neoplasms of bronchus or lung
Malignant neoplasms of cervix uteri
Other specified gliomas of brain
Malignant neoplasms of lip, oral cavity or pharynx
Malignant neoplasms of kidney, except renal pelvis
Other specified malignant neoplasms of the ovary
Germ cell tumour of testis